Etanercept-induced injection site reactions: mechanistic insights from clinical findings and immunohistochemistry.
Werth
V P
VP
Levinson
A I
AI
D000276:Adjuvants, Immunologic; D015703:Antigens, CD / Q000378:metabolism; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000378:metabolism; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D004342:Drug Hypersensitivity / Q000276:immunology* / Q000378:metabolism; D000068800:Etanercept; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000276:immunology* / Q000378:metabolism; D007150:Immunohistochemistry; D016130:Immunophenotyping; D007271:Injections, Intradermal; D018124:Receptors, Tumor Necrosis Factor / Q000276:immunology* / Q000378:metabolism
D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept